People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| XYLOS Corp | — | Biotechnology | Seed | $2.6M | $17.8M | 2010 |
John M. Pietruski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John M. Pietruski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric T. Converse | 1 | 1 |
| Mark S. McNulty | 1 | 1 |
| Gregory M. Zaic | 1 | 1 |
| Constance L. Ace | 1 | 1 |
| Gonzalo C. Serafica | 1 | 1 |
| Paul J. Gordon | 1 | 1 |
| Seth S. Pierrepont | 1 | 1 |
| David S. Rovee | 1 | 1 |
| Frits M. Vromen | 1 | 1 |
| Richard S. Mink | 1 | 1 |
| Constance J. Ace | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.